Clinical Trial Update: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of galantamine in Alzheimer's disease patients who did not benefit from donepezil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED